Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsWithin the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
1.
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC
2.
Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
5.
TULSA Is Effective in Long-Term Prostate Cancer Control.
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
3.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
4.
Interpreting Iron Studies: What Your Blood Results Really Mean
5.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation